KRAS and lung carcinoma: In previous studies, it has been revealed that in oncogenic K-ras-induced lung cancer mouse model, genetic alteration of p65 subunit of NFκB reduces tumorigenesis (19)62 thereby substantiating the contribution of p65NFκB in activated Ras-induced tumor formation.